Mental Health 3D Glass Emblem
HEALTHGHURU EDITORIAL TOPIC HUB

MENTAL HEALTH

Evidence-based reporting, clinical research breakthroughs, doctor interviews, and validated wellness guides in Mental Health.

24+ Articles Available
Updated Daily
Clinically Sourced

Medically Verified Hub

Reviewed by board-certified physicians

ISO / Peer-Review Standards
Mindfulness Exercises May Support Psychotherapy for Adolescents
FEATURED IN MENTAL HEALTH
Mental Health•Oct 18, 2026

Mindfulness Exercises May Support Psychotherapy for Adolescents

Medical Xpress reported on 16 October that a study from Heidelberg University's Centre for Psychosocial Medicine found that a brief mindfulness exercise at the start of psychotherapy could support treatment for adolescent patients.

HealthGhuru BureauRead Report

Latest Mental Health Stories

Showing 23 articles

Topic:
Social Media Detox Research Leaves Important Questions About Youth Mental Health Unresolved
Mental Health11 min read
HealthGhuru BureauOct 16, 2026

Social Media Detox Research Leaves Important Questions About Youth Mental Health Unresolved

Research reported on 16 October 2026 examined the evidence behind social media detox programs and their effects on youth mental health. The review found that important questions remain unresolved, including which young people benefit, how long changes in social media use need to last, and which psychological outcomes improve. The findings suggest that a universal social media break should not be treated as a proven solution for every mental health problem.

Experimental Hand Sanitizer Formulation Linked to Fewer Respiratory Symptoms in a Randomized Trial
General Health11 min read
HealthGhuru BureauOct 15, 2026

Experimental Hand Sanitizer Formulation Linked to Fewer Respiratory Symptoms in a Randomized Trial

A randomized trial in Japan involving 568 participants compared an experimental hand sanitizer containing ethanol, benzalkonium chloride, and lactic acid with a commercial ethanol-based sanitizer. Over 72 days, participants using the experimental formulation experienced a 40% lower cumulative incidence of upper respiratory symptoms. However, infections were not laboratory-confirmed, and the proposed mechanism of longer-lasting antimicrobial protection was not directly tested. The findings require further evaluation before the formulation can be recommended as superior for routine public-health use.

Targeting Specific Brain Circuits May Improve Treatment Outcomes for Severe Depression
Mental Health11 min read
HealthGhuru BureauOct 15, 2026

Targeting Specific Brain Circuits May Improve Treatment Outcomes for Severe Depression

Researchers reported that stimulating specific brain connections was associated with sustained improvement in people receiving deep brain stimulation for treatment-resistant depression. The findings suggest that the location and connectivity of stimulation may be important in determining clinical outcomes. The work could help refine future neuromodulation approaches, although deep brain stimulation remains a specialized intervention rather than a routine treatment for depression.

Exercise Associated With Better Cognitive Performance in People With Bipolar Disorder
Mental Health11 min read
HealthGhuru BureauOct 14, 2026

Exercise Associated With Better Cognitive Performance in People With Bipolar Disorder

Medical news coverage published on 13 October 2026 highlighted research examining the association between exercise and cognition in people with bipolar disorder. The findings add to continuing interest in how physical activity may support cognitive health alongside established psychiatric treatment. Because the available report provides limited methodological detail, the size and clinical significance of the association should be interpreted cautiously.

BioNTech's Experimental mRNA Cancer Immunotherapy Fails to Meet Primary Trial Goal
Cancer12 min read
HealthGhuru BureauOct 14, 2026

BioNTech's Experimental mRNA Cancer Immunotherapy Fails to Meet Primary Trial Goal

BioNTech announced on 13 October 2026 that its experimental mRNA-based cancer immunotherapy did not meet the primary endpoint of a mid-to-late-stage clinical trial involving patients with head and neck cancer. The result represents a setback for the company's efforts to expand mRNA technology beyond infectious diseases and into cancer treatment. It also highlights why promising early-stage results must be confirmed in larger clinical trials.